Stress and Diabetes
Stress raises blood glucose and worsens glycemic control in people with diabetes through both physiological and behavioral pathways, and chronic stress is also an independent risk factor for developing type 2 diabetes.
Physiological mechanism. Acute stress activates the sympathetic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis, releasing epinephrine and cortisol. Epinephrine increases hepatic glucose production and inhibits insulin secretion, while cortisol mobilizes energy stores, drives gluconeogenesis, reduces muscle glycogen synthesis, and suppresses insulin secretion — effects that onset within minutes and can last several hours.[1][2] In diabetes, the underlying insulin deficiency or insulin resistance prevents the normal return to glucose homeostasis, so these adaptive responses produce sustained hyperglycemia.[1] Glucocorticoids specifically induce insulin resistance across multiple tissues: upregulating hepatic gluconeogenic enzymes (PEPCK, G6Pase), impairing GLUT4-mediated glucose uptake in muscle and fat, and impairing β-cell function and GLP-1 insulinotropic effects.[3][4][5]
Both hyper- and hypoglycemia risk. The ADA Standards of Care 2026 note that stressful events (illness, trauma, surgery) increase the risk of both hyperglycemia and hypoglycemia, and in severe cases may precipitate life-threatening hyperglycemic crises (DKA, hyperosmolar states) — particularly in patients with clinical complexity and polypharmacy.[6]
Acute stress in the inpatient setting. Acute stress impairs glucose control in both type 1 and type 2 diabetes, and stress-related dysglycemia (hyper- or hypoglycemia) in the hospital predicts short- and long-term morbidity and mortality in critical illness.[7]
Chronic/psychological stress. Beyond acute effects, repeated stress produces chronic allostatic load with dysregulated cortisol rhythms, low-grade inflammation, and neuroendocrine dysregulation. Dysregulation of the diurnal cortisol profile predicts incident T2DM, and depression, chronic work stress, and early-life adversity are established risk factors.[8] Real-world CGM data show that higher perceived daily stress is associated with elevated glucose specifically in insulin-resistant individuals.[2] Higher perceived stress also correlates with higher HbA1c in type 1 diabetes.[9]
Behavioral pathway. Stress and diabetes-related distress impair self-care — diet, physical activity, glucose monitoring, and medication adherence — which independently worsens glycemic control. Depressive symptoms and diabetes distress amplify the stress-A1c link, while coping skills, perceived control, and positive affect can buffer it.[10][8]
The following figure illustrates the multi-organ pathophysiology by which glucocorticoids (the central mediator of the stress response) produce hyperglycemia and insulin resistance:
Clinical implications. Any patient with diabetes experiencing illness or a stressful event should be assessed for more frequent glucose monitoring, with ketone monitoring in ketosis-prone individuals; treatment should be reassessed (e.g., holding metformin/SGLT2 inhibitors if oral intake cannot be maintained or with concern for AKI).[6] Stress management interventions (cognitive behavioral therapy, mindfulness) reliably reduce diabetes distress, depression, and anxiety, but their effect on HbA1c is inconsistent; treating comorbid depression, particularly with SSRIs, has shown improvement in glycemic control.[8] In patients with difficult-to-control T2DM (HbA1c >8% despite multiple agents), consider evaluating for occult endogenous hypercortisolism, which has an estimated prevalence of 5-33% in this population.[5]
Would you like to explore sick-day management protocols for diabetes during acute illness?
References
  1. Psychosocial predictors of short-term glucose among people with diabetes: A narrative review. Horner FS, Helgeson VS. Journal of Behavioral Medicine. 2025;48(2):207-229. doi:10.1007/s10865-024-00536-9.
  2. Daily life stress is linked to increased glucose levels in individuals with insulin resistance: a real-world assessment. Schrems E, Gruber JR, Schiweck C, et al. Diabetologia. 2025;68(12):2709-2718. doi:10.1007/s00125-025-06552-x.
  3. Hypercortisolism: Causes, Consequences and Clinical Significance – A Review of Pathophysiology. Eldib M, Fierro FE, Abad MO, Correa R. Diabetes, Obesity & Metabolism. 2026;. doi:10.1111/dom.71022.
  4. Diabetes in Cushing Disease. Mazziotti G, Formenti AM, Frara S, et al. Current Diabetes Reports. 2017;17(5):32. doi:10.1007/s11892-017-0860-9.
  5. Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Buse JB, Kahn SE, Aroda VR, et al. Diabetes Care. 2025;48(12):2012-2020. doi:10.2337/dc24-2841.
  6. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care. 2026;49(Supplement_1):S132-S149. doi:10.2337/dc26-S006.
  7. Neural Regulation of Blood Glucose in Acute Stress: A Report on Research Supported by Pathway to Stop Diabetes. Stanley SA. Diabetes. 2026;75(1):5-16. doi:10.2337/dbi24-0051.
  8. Type 2 diabetes mellitus and psychological stress — a modifiable risk factor. Hackett RA, Steptoe A. Nature Reviews. Endocrinology. 2017;13(9):547-560. doi:10.1038/nrendo.2017.64.
  9. Effect of perceived stress, concern about hypoglycaemia and level of knowledge of management of the disease on glycaemic control in type 1 diabetes mellitus. Grau-Del Valle C, Marco-Expósito JF, Bosch-Sierra N, et al. Journal of Clinical Nursing. 2023;32(1-2):264-272. doi:10.1111/jocn.16270.
  10. Stress and A1c Among People with Diabetes Across the Lifespan. Hilliard ME, Yi-Frazier JP, Hessler D, et al. Current Diabetes Reports. 2016;16(8):67. doi:10.1007/s11892-016-0761-3.
0
0 comments
Elven Smith
1
Stress and Diabetes
powered by
skool.com/elven-conrad-smith-5531
MISSION: SAVE 1 MILLION CHILDREN FROM RAVAGES OF DIABETES
Build your own community
Bring people together around your passion and get paid.
Powered by